EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MAY 13, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.2028?guestAccessKey=b6c247eb-80fd-4387-a323-7b2d16344e37&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051320
What The Study Did: This report assesses the risk associated with COVID-19 for pediatric patients with cancer.
Authors: Andrew L. Kung, M.D., Ph.D., of Memorial Sloan Kettering Cancer Center in New York, is the corresponding author.
Editor’s Note: The article includes funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.